Literature DB >> 2727930

First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy.

M F Greene1, J W Hare, J P Cloherty, B R Benacerraf, J S Soeldner.   

Abstract

The relationship between the level of hemoglobin A1 (Hb A1) in the first trimester and major malformations and spontaneous abortions was examined in 303 insulin-requiring diabetic gravidas. During the study period, all patients with insulin-requiring diabetes mellitus antedating pregnancy who registered for prenatal care prior to 12 weeks' gestation and who had a known outcome were included. Thirty-five percent of the patients entered with a first-trimester Hb A1 of greater than 11.0% of total hemoglobin (9 standard deviations above the mean for a nondiabetic population). A broad spectrum of glycemic control was therefore represented. The risk of spontaneous abortion was 12.4% with first-trimester Hb A1 less than or equal to 9.3% and 37.5% with Hb A1 greater than 14.4% (risk ratio 3.0; 95% confidence interval 1.3-7.0). The risk for major malformation was 3.0% with Hb A1 less than or equal to 9.3% and 40% with Hb A1 greater than 14.4% (risk ratio 13.2; 95% confidence interval 4.3-40.4). Although the risks for both adverse outcomes were markedly elevated following a first trimester in very poor metabolic control, there was a broad range of control over which the risks were not substantially elevated. To keep malformations and spontaneous abortions to a minimum among diabetic women does not require "excellent" control; there seems to be a fairly broad range of "acceptable" control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2727930     DOI: 10.1002/tera.1420390303

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  40 in total

Review 1.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  Protecting the terminus: t-loops and telomere end-binding proteins.

Authors:  C Wei; M Price
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

3.  Diabetic embryopathy: a developmental perspective from fertilization to adulthood.

Authors:  M Castori
Journal:  Mol Syndromol       Date:  2013-02

4.  ASK1 mediates the teratogenicity of diabetes in the developing heart by inducing ER stress and inhibiting critical factors essential for cardiac development.

Authors:  Fang Wang; Yanqing Wu; Michael J Quon; Xuezheng Li; Peixin Yang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-14       Impact factor: 4.310

Review 5.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

6.  SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy.

Authors:  Hongbo Weng; Xuezheng Li; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2012-02-22       Impact factor: 8.661

7.  Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells.

Authors:  Michael Balistreri; Justin A Davis; Katherine F Campbell; André Monteiro Da Rocha; Marjorie C Treadwell; Todd J Herron
Journal:  Pediatr Cardiol       Date:  2017-07-27       Impact factor: 1.655

Review 8.  New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects.

Authors:  Daoyin Dong; E Albert Reece; Xue Lin; Yanqing Wu; Natalia AriasVillela; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2015-09-30       Impact factor: 8.661

9.  Shell-less chick embryo culture as an alternative in vitro model to investigate glucose-induced malformations in mammalian embryos.

Authors:  Savita Datar; Ramesh R Bhonde
Journal:  Rev Diabet Stud       Date:  2006-02-10

Review 10.  New concepts in diabetic embryopathy.

Authors:  Zhiyong Zhao; E Albert Reece
Journal:  Clin Lab Med       Date:  2013-04-19       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.